Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001346824-25-000052·BIOCRYST PHARMACEUTICALS INC
Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Common Stock, $0.01 par value per share · CUSIP: 09058V103
Event date: 2025-11-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 15,302,186.00 · Class: 7.3%
- Peter Kolchinsky
Shares: 15,302,186.00 · Class: 7.3%
- Rajeev Shah
Shares: 15,302,186.00 · Class: 7.3%
- RA Capital Healthcare Fund, L.P.
Shares: 15,302,186.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000052
- Form type
- SCHEDULE 13G
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Nov 12, 2025
- Reporting period
- Nov 04, 2025
- Description
- Schedule 13G beneficial ownership